TabTrade Launches With 0.0 Pips Average Spreads, Targeting Lowest Spread Forex Broker Positioning

WILMINGTON, Del., March 11, 2026 /PRNewswire/ -- Oak-Eagle AcquireCo, Inc. (the "Offeror") announced today the extension of the Expiration Time...

Media Advisory – Media registration: National Summit on Artificial Intelligence and Culture

Media are invited to participate in the National Summit on Artificial Intelligence and Culture in Banff from March 15 to...

Best ERP Solutions for Manufacturing (2026): Sage Named UK’s Top Choice for Operations and Inventory Management by Expert Consumers

NEW YORK, March 11, 2026 /PRNewswire/ -- Sage has been named the UK's top choice for operations and inventory management in...

INVESTOR ALERT: Navan, Inc. Investors with Substantial Losses Have Opportunity to Lead the Navan Class Action – RGRD Law

SAN DIEGO, March 11, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Navan, Inc....

Gray Media Forces Blackout of 226 Local Channels, Disrupting DISH TV Customers Nationwide

ENGLEWOOD, Colo., March 10, 2026 /PRNewswire/ -- Following Gray Media's decision to black out its local stations from the DISH...

Rev1 Ventures Launches National Search for Next CEO to Lead Next Decade of Growth

Tom Walker to Transition to Executive Chairman; Kristy Campbell to Support Leadership Transition for Midwest Venture StudioCOLUMBUS, Ohio, March 10,...

America First Refining Secures Landmark 20-Year Offtake Agreement and Capital Investment to Construct First New U.S. Refinery in 50 years.

Transaction Represents Largest Energy Deal in U.S. History. BROWNSVILLE, Texas, March 10, 2026 /PRNewswire/ -- America First Refining announced a historic...

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Agent Ecosystem Application Progress and Infrastructure Development

LOS ANGELES, March 10, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ: AIXC) ("AIxC" or the "Company"), a technology company focused on...

Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting